Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Hoffman effect

  • Open Access
    Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics November 2024, 21 (6) 585-590; DOI: https://doi.org/10.21873/cgp.20475
  • Open Access
    Induction of the DNA-Repair Gene POLQ only in BRCA1-mutant Breast-Cancer Cells by Methionine Restriction
    TOMONARI KUNIHISA, SACHIKO INUBUSHI, HIROKAZU TANINO and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics July 2024, 21 (4) 399-404; DOI: https://doi.org/10.21873/cgp.20458
  • Open Access
    The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of C-MYC
    YUSUKE AOKI, YUTARO KUBOTA, QINGHONG HAN, NORIYUKI MASAKI, KOYA OBARA, MICHAEL BOUVET, SANT P. CHAWLA, YASUNORI TOME, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics December 2023, 20 (6suppl) 679-685; DOI: https://doi.org/10.21873/cgp.20415
  • Open Access
    Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells
    SACHIKO INUBUSHI, TOMONARI KUNIHISA, SACHIKO MIZUMOTO, SHOTARO INOUE, MAYUKO MIKI, ATSUSHI SUETSUGU, HIROKAZU TANINO and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics September 2023, 20 (5) 412-416; DOI: https://doi.org/10.21873/cgp.20393
  • Open Access
    Oncogenes and Methionine Addiction of Cancer: Role of c-MYC
    YUSUKE AOKI, QINGHONG HAN, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics March 2023, 20 (2) 165-170; DOI: https://doi.org/10.21873/cgp.20371
  • Open Access
    Oral Installation of Recombinant Methioninase-producing Escherichia coli into the Microbiome Inhibits Colon-cancer Growth in a Syngeneic Mouse Model
    YUTARO KUBOTA, QINGHONG HAN, KAZUYUKI HAMADA, YUSUKE AOKI, NORIYUKI MASAKI, KOYA OBARA, ANTON BARANOV, MICHAEL BOUVET, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics November 2022, 19 (6) 683-691; DOI: https://doi.org/10.21873/cgp.20351
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire